Press Releases & Media Statements
May 13, 2024
New agreement with Quallent expands biosimilar access
May 02, 2024
Improving Access to Clinical Trials
May 01, 2024
FDA Approves Additional Formulation of Our Biosimilar
Past Events
Human Health Innovation
Transforming Science Day
Media Contacts
Head, U.S. Communications Human Pharma
900 Ridgebury Rd.
P.O. Box 368
Ridgefield, CT 06877
Boehringer Ingelheim Animal Health USA Inc.
U.S. Communications
Phone +1 (516) 527-5456